Nanoscale, 2015, Advance Article
DOI: 10.1039/C5NR05139H, Paper
DOI: 10.1039/C5NR05139H, Paper
Qiuyu Qu, Xing Ma, Yanli Zhao
Targeting ligand triphenoylphosphonium-conjugated mesoporous silica nanoparticles were developed to deliver the anticancer drug doxorubicin to mitochondria, achieving enhanced cancer cell killing efficacy.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
Targeting ligand triphenoylphosphonium-conjugated mesoporous silica nanoparticles were developed to deliver the anticancer drug doxorubicin to mitochondria, achieving enhanced cancer cell killing efficacy.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
Click for full article
No comments:
Post a Comment